Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45,609 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial.
Cao Y, Wei J, Zou L, Jiang T, Wang G, Chen L, Huang L, Meng F, Huang L, Wang N, Zhou X, Luo H, Mao Z, Chen X, Xie J, Liu J, Cheng H, Zhao J, Huang G, Wang W, Zhou J. Cao Y, et al. Among authors: wang g, wang w, wang n. J Allergy Clin Immunol. 2020 Jul;146(1):137-146.e3. doi: 10.1016/j.jaci.2020.05.019. Epub 2020 May 26. J Allergy Clin Immunol. 2020. PMID: 32470486 Free PMC article. Clinical Trial.
[Anti-CD22 CAR-T combined with anti-CD19 CAR-T cells in the treatment of relapsed or refractory acute B lymphocytic leukemia with severe cytokine release syndrome: two cases report and literature review].
Gao LL, Huang L, Wang N, Wang GX, Zhou XX, Li TJ, Hong ZY, Meng L, Zhou JF. Gao LL, et al. Among authors: wang gx, wang n. Zhonghua Xue Ye Xue Za Zhi. 2019 Sep 14;40(9):780-782. doi: 10.3760/cma.j.issn.0253-2727.2019.09.016. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31648485 Free PMC article. Review. Chinese. No abstract available.
Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies.
Wang N, Hu X, Cao W, Li C, Xiao Y, Cao Y, Gu C, Zhang S, Chen L, Cheng J, Wang G, Zhou X, Zheng M, Mao X, Jiang L, Wang D, Wang Q, Lou Y, Cai H, Yan D, Zhang Y, Zhang T, Zhou J, Huang L. Wang N, et al. Among authors: wang g, wang d, wang q. Blood. 2020 Jan 2;135(1):17-27. doi: 10.1182/blood.2019000017. Blood. 2020. PMID: 31697824 Free article. Clinical Trial.
CAR T Cell Therapy for Hematological Malignancies.
Yang X, Wang GX, Zhou JF. Yang X, et al. Curr Med Sci. 2019 Dec;39(6):874-882. doi: 10.1007/s11596-019-2118-z. Epub 2019 Dec 16. Curr Med Sci. 2019. PMID: 31845217 Review.
CAR T-cell therapy for a relapsed/refractory acute B-cell lymphoblastic lymphoma patient in the context of Li-Fraumeni syndrome.
Chen L, Xu B, Long X, Gu J, Lou Y, Wang D, Cao Y, Wang N, Li C, Wang G, Wang Y, Zhu L, Wang J, An H, Xiao M, Xiao Y, Zhou J. Chen L, et al. Among authors: wang g, wang j, wang y, wang n, wang d. J Immunother Cancer. 2020 Apr;8(1):e000364. doi: 10.1136/jitc-2019-000364. J Immunother Cancer. 2020. PMID: 32345625 Free PMC article.
45,609 results
You have reached the last available page of results. Please see the User Guide for more information.